Navigation Links
Vaginal Mesh Lawsuit News: Wright & Schulte LLC Applaud $2 Million Verdict in C.R. Bard Transvaginal Mesh Lawsuit Trial
Date:8/18/2013

Columbus, OH (PRWEB) August 18, 2013

The vaginal mesh lawsuit lawyers at Wright & Schulte LLC, an experienced medical device law firm, are extremely pleased that the jury hearing arguments in the first federal bellwether trial of a vaginal mesh lawsuit has seen fit to award a woman injured by C.R. Bard’s Avaulta Plus device $2 million in damages. According to court documents filed in U.S. District Court, Southern District of West Virginia, the 8-member jury found that the Avaulta Plus mesh was defective, and that C.R. Bard failed to warn about the problems with the product. The Plaintiff, a 45-year-old woman from Georgia, was awarded $250,000 in compensatory damages and $1.75 million in punitive damages following 11 days of testimony and 12 hours of deliberations. (Cisson v. C.R. Bard Inc., 11-cv- 00195)

Wright & Schulte LLC, believes the outcome of this vaginal mesh lawsuit is a significant victory for all alleged victims of vaginal mesh complications, as rulings in bellwether trials are often used to gauge the strength of plaintiffs ‘claims in similar cases. The Firm is already representing numerous women who have allegedly experienced painful transvaginal mesh or bladder mesh complications due to products manufactured by C.R. Bard and other companies. If you or someone you love suffered serious, life-altering vaginal mesh injuries following implantation of pelvic mesh to treat pelvic organ prolapse or stress urinary incontinence, please visit yourlegalhelp.com, or call toll-FREE 1-800-399-0795 to learn more about your options for legal recourse.

According to court documents, the transvaginal mesh lawsuit at trial in West Virginia was filed by a woman who underwent multiple corrective surgeries after receiving C.R. Bard’s Avaulta Plus product in 2009. According to a report from Bloomberg News, she claimed that C.R. Bard knowingly used a plastic resin in those devices that was not fit to be permanently implanted in humans. The case was the first of four bellwethers scheduled in the multidistrict litigation underway in the Southern District of West Virginia for C.R. Bard vaginal mesh lawsuits. The second of those trials is scheduled to begin on Tuesday, August 19th. (In re C.R. Bard Inc. Pelvic Repair System Products Liability Litigation, MDL No. 2187)
[bloomberg.com/news/2013-08-15/bard-loses-250-000-verdict-in-vaginal-mesh-implant-trial.html]

This marks the third trial loss in a row for transvaginal mesh manufacturers, and the second loss for C.R. Bard. Last July, the company was ordered to pay $3.6 million to another victim of Avaulta Plus in a case that went to trial in California Superior Court. (Scott v. Kannappan, S-1500-CV-266034-WDE ) In March, the New Jersey Superior Court jury hearing the nation’s first trial of an Ethicon Inc. transvaginal mesh lawsuit awarded more than $11 million to a woman injured by the Gynecare Prolift device. (Gross v. Gynecare Inc., Atl-L-6966-10)

In addition to the C.R. Bard litigation, several other multidistrict litigations are pending in the Southern District of West Virginia for vaginal mesh lawsuits involving other device manufacturers, including:

  •     In re: American Medical Systems, Inc., Pelvic Repair Systems Products Liability Litigation (MDL No. 2325)
  •     In re: Boston Scientific Corp., Pelvic Repair System Products Liability Litigation (MDL No. 2326);
  •     In re: Ethicon, Inc., Pelvic Repair System Products Liability Litigation (MDL No. 2327)
  •     In Re: Coloplast Corp. Pelvic Support System Products Liability Litigation (MDL No. 2387)

About Wright & Schulte LLC
Wright & Schulte LLC, a defective medical device law firm, is dedicated to the belief that America’s legal system should work for the people. Every day, the attorneys of Wright & Schulte LLC stand up for the rights of people who have been injured or wronged by defective drugs and their side effects, complications from defective medical devices, and unsafe consumer products, and fight tirelessly to ensure that even the world’s most powerful corporations take responsibility for their actions. If you’re looking for a law firm that will guarantee the aggressive and personal representation you deserve, please do not hesitate to contact Wright & Schulte LLC today. Free case evaluations are available through yourlegalhelp.com, or call 1-800-399-0795. For current information visit and like our Vaginal Mesh Lawsuit Facebbok page.

Contact:
Wright & Schulte LLC
812 East National Road
Vandalia, Ohio 45377
1-800-399-0795
http://www.yourlegalhelp.com

Read the full story at http://www.prweb.com/releases/2013/8/prweb11038056.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Vaginal Mesh Lawsuits Proceed Against Ethicon, as Bernstein Liebhard LLP Notes Order for Discovery Conferences in Federal Ethicon Litigation
2. Vaginal Mesh Lawsuit News: Plaintiff in First Federal Bellwether Trial of C.R. Bard Vaginal Mesh Lawsuit Awarded $2 Million
3. Jury Awards Transvaginal Mesh Patient $2M, Finding that C.R. Bard Failed to Warn of the Dangers of Its Avaulta Pelvic Mesh Device, Notes Parker Waichman LLP
4. Vaginal Mesh Lawsuit News: Jury Awards $2 Million to Plaintiff in First C.R. Bard Vaginal Mesh Lawsuit, Reports Alonso Krangle LLP
5. Transvaginal Mesh Lawsuit News: Rottenstein Law Group LLP Responds to $2 Million Bard Mesh Trial Verdict
6. Transvaginal Mesh Lawsuit News: Rottenstein Law Group LLP Responds to $250,000 Bard Mesh Trial Verdict
7. Transvaginal Mesh Lawsuit News: Bernstein Liebhard LLP Notes Start of Jury Deliberations in First Federal Bellwether Trial of C.R. Bard Vaginal Mesh Lawsuit
8. Transvaginal Mesh Multidistrict Litigation Update: Court Issues New Pretrial Order that Moves Ethicon Inc.’s Discovery Forward, Notes Parker Waichman
9. Vaginal Mesh Lawsuit News: Bernstein Liebhard LLP Notes New Order in Federal Litigation for American Medical Systems Mesh Lawsuits
10. Vaginal Mesh Lawsuit Lawyers at Wright & Schulte LLC Report on Developments in First Federal Trial of C.R. Bard Vaginal Mesh Lawsuit
11. Mesh Lawsuit News: Bernstein Liebhard LLP Notes Issuance of New Order in Federal Boston Scientific Transvaginal Mesh Litigation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2017)... ... April 21, 2017 , ... Young Asset Protection, an insurance ... throughout the greater Pittsburgh metropolitan region, is joining forces with the local chapter ... differently-abled children. , Variety the Children’s Charity is a national organization dedicated to ...
(Date:4/21/2017)... ... April 21, 2017 , ... The Hong Kong Polytechnic University (PolyU) launched ... among higher education institutions in Hong Kong to support teaching, learning and research. It ... and quantity of facilities in Hong Kong. , With an area of 620 ...
(Date:4/21/2017)... , ... April 21, 2017 , ... ... held the much anticipated Regional Primary Care Spring Symposium on April 1, 2017 ... local medical community, offering physicians and healthcare providers an opportunity to learn about ...
(Date:4/21/2017)... , ... April 21, 2017 , ... Westside Dental ... personalized dental care since 1985. After thirty-two years, Dr. Latner has become one of ... help my numerous clients over the years with all their dental needs,” said Dr. ...
(Date:4/21/2017)... ... April 21, 2017 , ... ... reveals good news for older shoulder replacement patients; post-operative recovery just might be ... two groups of patients presenting with osteoarthritis following surgery: 262 patients under 65 ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... DUBLIN , April 20, 2017 ... the "Global Biosimilar Pipeline and Market Prospects: Addressing ... report to their offering. ... "Global Biosimilar Pipeline and Market ... by Design" provides an in-depth assessment of the current ...
(Date:4/20/2017)... 20, 2017  AbbVie (NYSE: ABBV), a global ... of chronic hepatitis C virus (HCV) infected patients ... and compensated cirrhosis (Child-Pugh A) achieved sustained virologic ... with its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). ... following 12 weeks of G/P treatment without ribavirin. ...
(Date:4/19/2017)... Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the "Company"), announces that it ... 2017 at the Sheraton Hotel in Toronto, Ontario ... the Company is scheduled to present on Tuesday, May 2 at ... Chairman of the Board, Tony Holler will also attend ... For more details ...
Breaking Medicine Technology: